Bicycle Therapeutics Shares Rise On Continuation Of BT8009 Development : vimarsana.com

Shares of Bicycle Therapeutics plc (BCYC) are up 9% on Monday after the company announced that it will proceed with its plan to expedite the development of BT8009 for metastatic bladder cancer.

Related Keywords

Kevin Lee , Nasdaq , Bicycle Therapeutics , Project Frontrunner , Bt8009 , Icycle Therapeutics Plc , Cyc ,